Skip to main content
. 2018 Nov 24;17:23–26. doi: 10.1016/j.bbrep.2018.11.005

Fig. 2.

Fig. 2

Evaluation of antitumor activity of P38B against CHO/dPDPN and CHO-K1. (A) CHO/dPDPN xenograft mice models on day 17. (B) CHO-K1 xenograft mice models on day 17. (C) Resected tumors of CHO/dPDPN xenografts. (D) Resected tumors of CHO-K1 xenografts. (E) Tumor weight of CHO/dPDPN xenografts (day 17). (F) Tumor weight of CHO-K1 xenografts (day 17). (G) Body weight of CHO/dPDPN xenografts (day 17). (H) Body weight of CHO-K1 xenografts (day 17). The values are presented as mean ± SEM. An asterisk indicates statistical significance (* P < 0.05, Tukey–Kramer's test). n.s.: not significant.